Henry Meds vs Opt Health

Official site clearly positions Henry Meds around trt, metabolic health and broader longevity support.

Telehealth availability makes it easier to compare remote-care convenience against clinic-led alternatives.

Lab or diagnostics integration makes the total care model easier to compare than a headline price alone.

Membership structure can make the first visible price look cleaner than the full long-term cost.

Covers both men and women, making it one of the more gender-inclusive telehealth hormone platforms in the directory.

Physician-led quarterly monitoring keeps the clinical model more rigorous than many direct-to-consumer hormone services.

Peptide therapy integration alongside hormones makes it a stronger option for users who want a broader optimization stack.

Membership is required — there is no option for a one-off consult or standalone lab panel.

Henry Meds: Membership structure can make the first visible price look cleaner than the full long-term cost.

Opt Health: Membership is required — there is no option for a one-off consult or standalone lab panel.

Henry Meds has the cleaner current edge if you care most about transparency and a broader decision trail.

Opt Health may still fit better if its geography, clinic structure, or narrower service mix is closer to what you want.

Both providers share TRT and Wellness Labs — compare pricing models for those specific services before deciding.

Henry Meds: Medication costs for semaglutide are listed separately from membership fees, which can create a higher-than-headline total for GLP-1 programs.

Opt Health: Medication changes, shipping, or premium tiers may still change the final bill.

Henry Meds: Cancellation terms are not prominently displayed on reviewed public pages. Likely a standard monthly subscription cancel policy.

Opt Health: Cancellation or pause terms were not clearly listed on the reviewed official pages and should be checked directly.

Henry Meds: Henry Meds publicly leads with $44/month TRT — the most aggressive testosterone pricing anchor in the current directory.

Opt Health: Men and women seeking physician-guided hormone optimization with peptide support through a single telehealth platform.

Henry Meds: Henry Meds publicly lists TRT at $44/month, positioning it as one of the lowest visible testosterone pricing anchors in the telehealth space. Semaglutide programs are listed separately and typically start around $297–$397/month depending on dose.

Opt Health: Opt Health shows a visible starting price of $149 per month, but deeper pricing detail is not fully public on the reviewed pages.

Henry Meds: Monthly subscription model with no listed enrollment fee. Labs are described as included in the membership pricing.

Opt Health: A recurring membership or subscription appears to be part of the offer, but the exact public fee still needs manual review.

Henry Meds: An online intake flow with clinician review is required before prescriptions are issued. No in-person visit required.

Opt Health: The public flow suggests clinician review or consultation before treatment begins.

Henry Meds: Insurance coverage was not listed on the reviewed pages. HSA/FSA eligibility is not clearly confirmed.

Opt Health: Insurance, HSA, or FSA handling was not fully verified from the reviewed official pages.

Henry Meds: Medication costs for semaglutide are listed separately from membership fees, which can create a higher-than-headline total for GLP-1 programs.

Opt Health: Medication changes, shipping, or premium tiers may still change the final bill.